BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25812653)

  • 1. Genomic landscapes of pancreatic neoplasia.
    Wood LD; Hruban RH
    J Pathol Transl Med; 2015 Jan; 49(1):13-22. PubMed ID: 25812653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in genomic profiling of adenosquamous carcinoma of the pancreas.
    Marcus R; Maitra A; Roszik J
    J Pathol; 2017 Nov; 243(3):271-272. PubMed ID: 28816351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis.
    Felsenstein M; Hruban RH; Wood LD
    Adv Anat Pathol; 2018 Mar; 25(2):131-142. PubMed ID: 28914620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent discoveries in cancer genetics of exocrine pancreatic neoplasia.
    Hahn SA; Schmiegel WH
    Digestion; 1998 Aug; 59(5):493-501. PubMed ID: 9705534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of pancreatic intraepithelial neoplasia.
    Feldmann G; Beaty R; Hruban RH; Maitra A
    J Hepatobiliary Pancreat Surg; 2007; 14(3):224-32. PubMed ID: 17520196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV; Basturk O; Cheng JD; Andea AA
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of pancreatic neuroendocrine tumors: implications for the clinic.
    Pea A; Hruban RH; Wood LD
    Expert Rev Gastroenterol Hepatol; 2015; 9(11):1407-19. PubMed ID: 26413978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic classification of pancreatic neoplasia.
    Matthaei H; Semaan A; Hruban RH
    J Gastroenterol; 2015 May; 50(5):520-32. PubMed ID: 25605630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
    Kim BY; Park MH; Woo HM; Jo HY; Kim JH; Choi HJ; Koo SK
    BMC Med Genet; 2017 Oct; 18(1):106. PubMed ID: 28969599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Characterization of Low- and High-Grade Pancreatic Mucinous Cystic Neoplasms Reveals Recurrent KRAS Alterations in "High-Risk" Lesions.
    Conner JR; Mariño-Enríquez A; Mino-Kenudson M; Garcia E; Pitman MB; Sholl LM; Srivastava A; Doyle LA
    Pancreas; 2017; 46(5):665-671. PubMed ID: 28196015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of Genomic Sequencing in Pediatric CNS Tumors.
    Bavle AA; Lin FY; Parsons DW
    Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic alterations in pancreatic cancer and their relevance to therapy.
    Takai E; Yachida S
    World J Gastrointest Oncol; 2015 Oct; 7(10):250-8. PubMed ID: 26483879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes.
    Bleeker FE; Lamba S; Rodolfo M; Scarpa A; Leenstra S; Vandertop WP; Bardelli A
    Hum Mutat; 2009 Feb; 30(2):E451-9. PubMed ID: 19058223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized therapy for pancreatic cancer: Do we need better targets, arrows, or both?
    O'Hayer KM; Brody JR
    Discov Med; 2016 Feb; 21(114):117-23. PubMed ID: 27011047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic and genomic profiling of pancreatic cancer.
    Ansari D; Torén W; Zhou Q; Hu D; Andersson R
    Cell Biol Toxicol; 2019 Aug; 35(4):333-343. PubMed ID: 30771135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
    Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
    Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Hallmarks of Thyroid Neoplasia.
    Giordano TJ
    Annu Rev Pathol; 2018 Jan; 13():141-162. PubMed ID: 29083981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Categorization of cancer through genomic complexity could guide research and management strategies.
    Horlings HM; Flanagan AM; Huntsman DG
    J Pathol; 2015 Aug; 236(4):397-402. PubMed ID: 25864408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology of pancreatic cancer: potential clinical implications.
    Sakorafas GH; Tsiotos GG
    BioDrugs; 2001; 15(7):439-52. PubMed ID: 11520255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
    Cheng F; Zhao J; Zhao Z
    Brief Bioinform; 2016 Jul; 17(4):642-56. PubMed ID: 26307061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.